IL216199A - A peptide containing the sequence ednimvtfrnqasr - Google Patents

A peptide containing the sequence ednimvtfrnqasr

Info

Publication number
IL216199A
IL216199A IL216199A IL21619911A IL216199A IL 216199 A IL216199 A IL 216199A IL 216199 A IL216199 A IL 216199A IL 21619911 A IL21619911 A IL 21619911A IL 216199 A IL216199 A IL 216199A
Authority
IL
Israel
Prior art keywords
peptide consisting
ednimvtfrnqasr
sequence
sequence ednimvtfrnqasr
peptide
Prior art date
Application number
IL216199A
Other languages
English (en)
Hebrew (he)
Other versions
IL216199A0 (en
Original Assignee
Apitope Int Nv
Apitope Technology Bristol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40834163&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL216199(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Apitope Int Nv, Apitope Technology Bristol Ltd filed Critical Apitope Int Nv
Publication of IL216199A0 publication Critical patent/IL216199A0/en
Publication of IL216199A publication Critical patent/IL216199A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL216199A 2009-05-18 2011-11-07 A peptide containing the sequence ednimvtfrnqasr IL216199A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0908515.0A GB0908515D0 (en) 2009-05-18 2009-05-18 Peptide
PCT/GB2010/000997 WO2010133834A2 (en) 2009-05-18 2010-05-17 Peptide

Publications (2)

Publication Number Publication Date
IL216199A0 IL216199A0 (en) 2012-01-31
IL216199A true IL216199A (en) 2015-11-30

Family

ID=40834163

Family Applications (1)

Application Number Title Priority Date Filing Date
IL216199A IL216199A (en) 2009-05-18 2011-11-07 A peptide containing the sequence ednimvtfrnqasr

Country Status (30)

Country Link
US (1) US8703705B2 (enExample)
EP (2) EP2465523B1 (enExample)
JP (1) JP5784009B2 (enExample)
KR (1) KR101673889B1 (enExample)
CN (1) CN102458445B (enExample)
AU (1) AU2010250957B2 (enExample)
BR (1) BRPI1012845A2 (enExample)
CA (1) CA2762020C (enExample)
CL (1) CL2011002893A1 (enExample)
CO (1) CO6460780A2 (enExample)
CY (1) CY1115832T1 (enExample)
DK (1) DK2465523T3 (enExample)
EA (1) EA027229B1 (enExample)
EC (1) ECSP11011540A (enExample)
ES (1) ES2525448T3 (enExample)
GB (1) GB0908515D0 (enExample)
HR (1) HRP20141182T1 (enExample)
IL (1) IL216199A (enExample)
MX (1) MX2011012270A (enExample)
MY (1) MY168207A (enExample)
NZ (2) NZ596300A (enExample)
PL (1) PL2465523T3 (enExample)
PT (1) PT2465523E (enExample)
RS (1) RS53671B1 (enExample)
SG (2) SG176138A1 (enExample)
SI (1) SI2465523T1 (enExample)
SM (1) SMT201400186B (enExample)
UA (1) UA110921C2 (enExample)
WO (1) WO2010133834A2 (enExample)
ZA (1) ZA201108446B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4382170A3 (en) 2009-12-06 2024-09-04 Bioverativ Therapeutics Inc. Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
CN104903347B (zh) * 2012-11-12 2020-02-21 艾匹托普国际股份有限公司 肽
GB201314052D0 (en) * 2013-08-06 2013-09-18 Apitope Int Nv Peptides
EA201691111A1 (ru) 2014-01-10 2017-01-30 Байоджен Ма Инк. Химерные белки фактора viii и их применение
PE20231949A1 (es) 2015-10-30 2023-12-05 Spark Therapeutics Inc VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA
KR20190090827A (ko) 2016-12-02 2019-08-02 바이오버라티브 테라퓨틱스 인크. 키메라 응고 인자를 사용해 혈우병성 관절증을 치료하는 방법
KR102914074B1 (ko) 2018-05-18 2026-01-16 바이오버라티브 테라퓨틱스 인크. A형 혈우병의 치료 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030062321A (ko) 2000-08-21 2003-07-23 아피토프 테크놀러지 (브리스톨) 리미티드 펩티드 선별 방법
US20040096456A1 (en) * 2000-12-01 2004-05-20 Conti-Fine Bianca M Method to treat hemophilia
WO2002096454A1 (en) 2001-05-31 2002-12-05 D. Collen Research Foundation Vzw Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
AU2002312660A1 (en) * 2001-05-31 2002-12-16 D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
MXPA04010061A (es) * 2002-04-18 2004-12-13 Merck Patent Gmbh Factor viii modificado.
GB0723712D0 (en) 2007-12-04 2008-01-16 Apitope Technology Bristol Ltd Peptides
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII

Also Published As

Publication number Publication date
EA027229B1 (ru) 2017-07-31
EP2432494A2 (en) 2012-03-28
PL2465523T3 (pl) 2015-03-31
WO2010133834A2 (en) 2010-11-25
NZ613713A (en) 2014-10-31
CA2762020A1 (en) 2010-11-25
AU2010250957B2 (en) 2015-01-15
KR20120023023A (ko) 2012-03-12
US20120121625A1 (en) 2012-05-17
MX2011012270A (es) 2011-12-12
UA110921C2 (uk) 2016-03-10
SI2465523T1 (sl) 2015-02-27
EP2465523B1 (en) 2014-10-01
CL2011002893A1 (es) 2012-08-17
DK2465523T3 (en) 2014-12-15
PT2465523E (pt) 2014-12-09
SG176138A1 (en) 2011-12-29
HK1173358A1 (en) 2013-05-16
SMT201400186B (it) 2015-01-15
CN102458445B (zh) 2014-06-11
JP2012527440A (ja) 2012-11-08
ES2525448T3 (es) 2014-12-23
US8703705B2 (en) 2014-04-22
EA201171430A1 (ru) 2012-05-30
NZ596300A (en) 2013-08-30
KR101673889B1 (ko) 2016-11-08
EP2465523A1 (en) 2012-06-20
ZA201108446B (en) 2013-01-30
MY168207A (en) 2018-10-15
ECSP11011540A (es) 2012-01-31
CO6460780A2 (es) 2012-06-15
GB0908515D0 (en) 2009-06-24
WO2010133834A3 (en) 2011-02-24
BRPI1012845A2 (pt) 2016-10-11
RS53671B1 (sr) 2015-04-30
JP5784009B2 (ja) 2015-09-24
IL216199A0 (en) 2012-01-31
CN102458445A (zh) 2012-05-16
SG190573A1 (en) 2013-06-28
HRP20141182T1 (hr) 2015-02-13
CY1115832T1 (el) 2017-01-25
CA2762020C (en) 2018-08-28
AU2010250957A1 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
PL2406399T3 (pl) Białka mirac
GB0913775D0 (en) Multispecific peptides
GB0914110D0 (en) Peptide libraries
ZA201300994B (en) Polypeptides
IL220161A0 (en) Oxyntomodulin peptide analogue
IL214365A0 (en) Antibiotic peptides
GB201012651D0 (en) Peptides
PL2588491T3 (pl) Nowy peptyd i jego zastosowanie
PL2496596T3 (pl) Peptydy terapeutyczne
EP2593595A4 (en) NOVEL PEPTIDES AND USES THEREOF
EP2480578A4 (en) MODIFICATION OF POLYPEPTIDE
GB0920981D0 (en) Peptides
GB0921995D0 (en) Antimicrobial peptides
PL2627668T3 (pl) Peptydy i ich zastosowanie
PL2464656T3 (pl) Nowy peptyd i jego zastosowanie
ZA201108446B (en) FViII-DERIVED PEPTIDES
GB201016494D0 (en) Polypeptide
IL240134A0 (en) new proteins
ZA201109283B (en) Protein
GB0724953D0 (en) Methods of peptide modification
ZA201203722B (en) Peptide
EP2512435A4 (en) AUTONELLANT COSMETIC PRODUCT
GB0920987D0 (en) Peptides
EP2415780A4 (en) SYNTHETIC PEPTIDE AND USES THEREOF
GB0900924D0 (en) Instant kofta

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees